{"id":"W2066047258","doi":"10.1016/j.critrevonc.2012.02.004","title":"Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Sunitinib; Axitinib; Bevacizumab; Medicine; Angiogenesis; Vascular endothelial growth factor; Sorafenib; Fibroblast growth factor; Lung cancer; Cancer research; Oncology; Platelet-derived growth factor receptor; Growth factor; Pharmacology; Internal medicine; Chemotherapy; Cancer; VEGF receptors; Receptor; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0009397522,0.0005681438,0.005352437,0.0003017171,0.0001375599,0.00001595594,0.0001314478,0.001312029,0.0003528316],"category_scores_gemma":[0.001395379,0.0004020015,0.0006246361,0.0003840424,0.0007034647,0.00009215107,0.0001686887,0.001011902,0.0002758432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002554535,"about_ca_system_score_gemma":0.0004554056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000808203,"about_ca_topic_score_gemma":0.0000292632,"domain_scores_codex":[0.9952987,0.001188401,0.001895239,0.0008374068,0.0001170561,0.0006632306],"domain_scores_gemma":[0.9970131,0.001517375,0.0003052793,0.0005035447,0.00009511692,0.0005655863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001077111,0.0006554184,0.001558727,0.008490537,0.0003574903,0.000254333,0.00004778708,6.093277e-10,3.486893e-8,0.007466934,0.002245832,0.9789121],"study_design_scores_gemma":[0.001062453,0.0002292396,0.0007116334,0.006551292,0.007623776,0.003083557,0.00002464805,0.000002028674,6.127492e-8,0.0001284954,0.9802846,0.0002981842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004629805,0.9921498,0.00002102356,0.002559425,0.001817458,0.002249624,0.00005834152,0.00004995635,0.001048073],"genre_scores_gemma":[0.00007886884,0.9937591,0.00319052,0.001127361,0.0007284948,0.0007494818,0.0002184984,0.0000612662,0.00008639556],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.978614,"threshold_uncertainty_score":0.9999845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1231491848558787,"score_gpt":0.5226966903665233,"score_spread":0.3995475055106446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}